55,986 XNAS Volume
XNAS 20 Mar, 2025 12:00 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Josh Miller | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.00 per share. | 16 Feb 2025 | 9 | 333 (0%) | 0% | 10 | 90 | Common Stock |
| Josh Miller | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.86 per share. | 16 Nov 2024 | 7 | 342 (0%) | 0% | 2.9 | 20 | Common Stock |
| Josh Miller | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.37 per share. | 16 Aug 2024 | 38 | 1,743 (0%) | 0% | 0.4 | 14 | Common Stock |
| Josh Miller | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.52 per share. | 16 May 2024 | 46 | 1,781 (0%) | 0% | 0.5 | 24 | Common Stock |
| Josh Miller | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.59 per share. | 16 Feb 2024 | 46 | 1,827 (0%) | 0% | 0.6 | 27 | Common Stock |
| Josh Miller | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.84 per share. | 16 Aug 2023 | 37 | 1,911 (0%) | 0% | 0.8 | 31 | Common Stock |
| Josh Miller | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.07 per share. | 16 May 2023 | 185 | 1,948 (0%) | 0% | 1.1 | 198 | Common Stock |
| Jiyoung Hwang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| James R. Sulat | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Jeffrey L. Cleland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Bali Muralidhar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Bali Muralidhar | Director | Purchase of securities on an exchange or from another person at price $ 0.19 per share. | 19 May 2022 | 1,472,126 | 8,449,126 (9%) | 1% | 0.2 | 285,151 | Common Stock |
| Matthias G. Schroff | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 2,324,550 | 2,324,550 | - | - | Employee Stock Option (right to buy) | |
| Elias D. Papadimas | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 424,000 | 424,000 | - | - | Employee Stock Option (right to buy) | |
| Sarah Longoria | Chief HR & Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 180,750 | 180,750 | - | - | Employee Stock Option (right to buy) | |
| Douglas E. Feltner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.91 per share. | 15 Nov 2021 | 7,500 | 15,000 (0%) | 0% | 0.9 | 6,825 | Common Stock |
| David A. Giljohann | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.91 per share. | 15 Nov 2021 | 7,500 | 38,666 (0%) | 0% | 0.9 | 6,825 | Common Stock |
| Elias D. Papadimas | Chief Accounting Officer | Purchase of securities on an exchange or from another person at price $ 1.38 per share. | 27 Aug 2021 | 10,000 | 10,000 (0%) | 0% | 1.4 | 13,800 | Common Stock |
| Andrew H. Sassine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Bali Muralidhar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Bosun S. Hau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Jeffrey L. Cleland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Timothy P. Walbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| James R. Sulat | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Douglas E. Feltner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 1.27 per share. | 14 May 2021 | 7,500 | 7,500 (0%) | 0% | 1.3 | 9,525 | Common Stock |
| Matthias G. Schroff | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 1.27 per share. | 14 May 2021 | 7,500 | 7,500 (0%) | 0% | 1.3 | 9,525 | Common Stock |
| David A. Giljohann | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.27 per share. | 14 May 2021 | 7,500 | 31,166 (0%) | 0% | 1.3 | 9,525 | Common Stock |
| Brian C. Bock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 600,000 | 600,000 | - | - | Employee Stock Option (right to buy) | |
| Douglas E. Feltner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 220,000 | 220,000 | - | - | Employee Stock Option (right to buy) | |
| Matthias G. Schroff | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 60,000 | 60,000 | - | - | Employee Stock Option (right to buy) | |
| Matthias G. Schroff | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 476,200 | 476,200 | - | - | Employee Stock Option (right to buy) | |
| David A. Giljohann | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 1,142,900 | 1,142,900 | - | - | Employee Stock Option (right to buy) | |
| Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2021 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Andrew H. Sassine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2021 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| James R. Sulat | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2021 | 43,386 | 43,386 | - | - | Stock Option (right to buy) | |
| Jay Venkatesan | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 06 Jul 2020 | 12,930 | 324,473 (0%) | 0% | 1.0 | 13,318 | Common Stock |
| Jay Venkatesan | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2020 | 9,310 | 0 | - | - | Stock Option (right to buy) | |
| Jay Venkatesan | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2020 | 12,930 | 0 | - | - | Stock Option (right to buy) | |
| Jay Venkatesan | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.65 per share. | 06 Jul 2020 | 9,310 | 311,544 (0%) | 0% | 0.7 | 6,052 | Common Stock |
| Chad A. Mirkin | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.83 per share. | 12 Jun 2020 | 10,195 | 11,257,629 (13%) | 0% | 2.8 | 28,852 | Common Stock |
| Bali Muralidhar | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 21,693 | 21,693 | - | - | Stock Option (right to buy) | |
| Chad A. Mirkin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 21,693 | 21,693 | - | - | Stock Option (right to buy) | |
| David R. Walt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 21,693 | 21,693 | - | - | Stock Option (right to buy) | |
| Timothy P. Walbert | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 21,693 | 21,693 | - | - | Stock Option (right to buy) | |
| Helen S. Kim | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 21,693 | 21,693 | - | - | Stock Option (right to buy) | |
| Jeffrey L. Cleland | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 21,693 | 21,693 | - | - | Stock Option (right to buy) | |
| Jay Venkatesan | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 21,693 | 21,693 | - | - | Stock Option (right to buy) | |
| Bosun S. Hau | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 21,693 | 21,693 | - | - | Stock Option (right to buy) | |
| Douglas E. Feltner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2020 | 400,000 | 400,000 | - | - | Employee Stock Option (right to buy) | |
| Chad A. Mirkin | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.65 per share. | 20 May 2020 | 49,649 | 64,649 (0%) | 0% | 0.7 | 32,272 | Common Stock |
| Chad A. Mirkin | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2020 | 49,649 | 0 | - | - | Stock Option (right to buy) | |
| David A. Giljohann | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2020 | 871,504 | 871,504 | - | - | Employee Stock Option (right to buy) | |
| David R. Walt | None | Purchase of securities on an exchange or from another person at price $ 1.21 per share. | 13 Mar 2020 | 291,066 | 2,058,777 (2%) | 0% | 1.2 | 352,859 | Common Stock |
| David S. Snyder | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.40 per share. | 12 Mar 2020 | 18,248 | 18,248 (0%) | 0% | 1.4 | 25,591 | Common Stock |
| Chad A. Mirkin | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.45 per share. | 12 Mar 2020 | 15,000 | 15,000 (0%) | 0% | 1.5 | 21,750 | Common Stock |
| David S. Snyder | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2020 | 230,200 | 230,200 | - | - | Employee Stock Option (right to buy) | |
| Bali Muralidhar | None | Purchase of securities on an exchange or from another person at price $ 2.75 per share. | 19 Dec 2019 | 727,000 | 6,977,000 (9%) | 0% | 2.8 | 1,999,250 | Common Stock $0.0001 par value |
| Bali Muralidhar | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2019 | 43,386 | 43,386 | - | - | Stock option (right to buy) | |
| Bosun S. Hau | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2019 | 43,386 | 43,386 | - | - | Stock Option (right to buy) | |
| Jay Venkatesan | None | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 02 Aug 2019 | 250,000 | 302,234 (0%) | 0% | 2 | 500,000 | Common Stock |
| David R. Walt | None | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 02 Aug 2019 | 1,000,000 | 1,767,711 (2%) | 1% | 2 | 2,000,000 | Common Stock |
| Chad A. Mirkin | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 02 Aug 2019 | 25,000 | 25,000 (0%) | 0% | 2 | 50,000 | Common Stock |